As determined by western blotting, the NLRP-3 level was slightly lower after monotreatment by Zn or BSE (P > 0.05) and significantly lower after combined treatment (P < 0.05) than that in the IH group (Figures 5(a) and 5(b)). The gene discussed is NLRP3; the disease is isolated hemihyperplasia.